The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells

Huang Wei Shen, Yu Lin Chen, Ching Yuh Chern, Wai Ming Kan

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Phorbol-12-myristate-13-acetate (PMA) induces megakaryocytopoeisis in human erythroleukemia (HEL) cells which is characterized by the increase in cell size, increase in nuclear polyploidization and expression of megakaryocyte marker, CD41. However, upon treatment with 100 nM of selective prostacyclin (IP) agonist beraprost inhibits the induced differentiation. Moreover, selective non-prostanoid IP agonist, BMY 45778 prevents PMA induced megakaryocytopoeisis in HEL cells similarly, while prostaglandin E2 and specific EP3 agonist sulprostone have no effect. Thus, IP receptor is involved. Furthermore, adenylate cyclase activator forskolin and cAMP analog dibutyryl-cAMP also prevented PMA induced megakaryocytopoeisis in HEL cells. Thus, IP agonists inhibition of PMA induced megakaryocytopoeisis in HEL cells may involve a cAMP dependent pathway.

Original languageEnglish
Pages (from-to)231-236
Number of pages6
JournalProstaglandins and Other Lipid Mediators
Volume83
Issue number3 SPEC. ISS.
DOIs
Publication statusPublished - 2007 May

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Fingerprint

Dive into the research topics of 'The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells'. Together they form a unique fingerprint.

Cite this